Zobrazeno 1 - 10 of 70 pro vyhledávání: '"Jenkins Mt"'
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.
Autor: Bowman RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: robert.bowman@pennmedicine.upenn.edu., Dunbar AJ; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mishra T; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Xiao W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Waarts MR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Maestre IF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Eisman SE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Cai L; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Mowla S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Shah N; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Youn A; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Bennett L; Department of Cell and Developmental Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Fontenard S; Department of Cell and Developmental Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Gounder S; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Gandhi A; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Bowman M; Department of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., O'Connor K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Zaroogian Z; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sánchez-Vela P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Martinez Benitez AR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Werewski M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Park Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Csete IS; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Krishnan A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lee D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Boorady N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Potts CR; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37212 USA., Jenkins MT; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37212 USA., Cai SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Leukemia Service, Department of Medicine and Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Carroll MP; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Meyer SE; Department of Cancer Biology, Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, PA 19107, USA., Miles LA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ferrell PB Jr; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37212 USA., Trowbridge JJ; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: leviner@mskcc.org.
Publikováno v: Cancer cell [Cancer Cell] 2024 Nov 11; Vol. 42 (11), pp. 1955-1969.e7.
Zobrazit plný text záznamu
7
Akademický článek
Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation.
Autor: Heimlich JB; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Bhat P; Vanderbilt University School of Medicine, Nashville, TN., Parker AC; Vanderbilt University School of Medicine, Nashville, TN., Jenkins MT; Vanderbilt University School of Medicine, Nashville, TN., Vlasschaert C; Department of Medicine, Queen's University, Kingston, ON, Canada., Ulloa J; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Van Amburg JC; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Potts CR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Olson S; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Silver AJ; Vanderbilt University School of Medicine, Nashville, TN., Ahmad A; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Sharber B; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Brown D; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Hu N; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., van Galen P; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Savona MR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Program in Cancer Biology, and Center for Immunobiology, Nashville, TN.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN., Bick AG; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Ferrell PB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Publikováno v: Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3665-3678.
Zobrazit plný text záznamu
8
Akademický článek
Development and profiling of mGlu 7 NAMs with a range of saturable inhibition of agonist responses in vitro.
Autor: Reed CW; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Rodriguez AL; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Kalbfleisch JJ; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Seto M; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Jenkins MT; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Blobaum AL; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Chang S; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States., Lindsley CW; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States; Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, TN 37232, United States; Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN 37232, United States; Vanderbilt Department of Chemistry, Vanderbilt University, Nashville, TN 37232, United States., Niswender CM; Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, United States; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, United States; Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, TN 37232, United States; Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, TN 37232, United States; Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, United States. Electronic address: colleen.niswender@vanderbilt.edu.
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2022 Oct 15; Vol. 74, pp. 128923. Date of Electronic Publication: 2022 Aug 06.
Zobrazit plný text záznamu
9
Akademický článek
ASHP Statement on Telehealth Pharmacy Practice.
Autor: Begnoche BR; Garnet Health Medical Center, Middletown, NY, USA., David Butler C; Teradata, Inc. Richmond, VA, USA., Carson PH; Atrium Health, Charlotte, NC, USA., Darr A; Avel eCARE, LLC, Sioux Falls, SD, USA., Jenkins MT; University of Virginia Health System, Charlottesville, VA, USA., Le T; UNC Health Care, Raleigh, NC, USA., McDaniel RB; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mourad H; Mayo Clinic, Jacksonville, FL, USA., Shipman CJ; Oregon Health and Science University, Portland, OR, USA., Stratton TP; University of Minnesota College of Pharmacy, Duluth, Duluth, MN, USA., Tran K; Houston, TX, USA., Wong KK; VA Capitol Health Care Network (VISN 5), Washington, DC, USA.
Publikováno v: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2022 Sep 22; Vol. 79 (19), pp. 1728-1735.
Zobrazit plný text záznamu
10
Akademický článek
Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia.
Autor: Sunthankar KI; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Jenkins MT; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Cote CH; University of Kansas School of Medicine, Kansas City, Kansas, USA., Patel SB; O'Neal Comprehensive Cancer Center, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Welner RS; O'Neal Comprehensive Cancer Center, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ferrell PB; Vanderbilt Ingram Cancer Center, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. brent.ferrell@vumc.org.
Publikováno v: Leukemia [Leukemia] 2022 Apr; Vol. 36 (4), pp. 923-934. Date of Electronic Publication: 2021 Dec 02.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje